Risk of Treatment-Related Toxicities from EGFR Tyrosine Kinase Inhibitors: A Meta-analysis of Clinical Trials of Gefitinib, Erlotinib, and Afatinib in Advanced EGFR -Mutated Non–Small Cell Lung Cancer
収録刊行物
-
- Journal of Thoracic Oncology
-
Journal of Thoracic Oncology 12 (4), 633-643, 2017-04
Elsevier BV